Effects of Biological Response Modifiers On Lung Natural Killer Activity

References

• Woodruff M FA. The cytolytic and regulatory role of natural killer cells in experimental neoplasia. Blochimica Blophysica Acta 1986; 865: 43
   PubMed Web of Science ®Google Scholar
• Barlouari T, Leonhardt J, Wiltrout R H, Herberman R B, Reynolds C W. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J. Immunol. 1985; 134: 2783
   PubMedGoogle Scholar
• Nolibe D, Aumaitre E, Thang M N. In vivo augmentation of rat lung natural killer cell activity and inhibition of experimental metastases by double stranded polynucleotides. Cancer Res. 1985; 45: 4774
   PubMed Web of Science ®Google Scholar
• Nolibe D, Poupon M F. Enhancement of pulmonary metastases induced by decreased lung natural killer activity. J. Natl. Cancer Inst. 1986; 77: 99
   PubMedGoogle Scholar
• Reynolds C W, Timonen T, Herberman R B. Natural killer (NK) cell activity in the Rat. I. Isolation and characterization of the effector cells. J. Immunol. 1981; 127: 282
   PubMed Web of Science ®Google Scholar
• Wiltrout R H, Mathieson B J, Talmadge J E, Reynolds C W, Zhang S-R, Herberman R B, Ortaldo J R. Augmentation of organ-associated natural killer activity by biological response modifiers: Isolation and characterization of large granular lymphocytes from the liver. J. Exp. Med. 1984; 160: 1431
   PubMed Web of Science ®Google Scholar
• Nuntirooj K, Bozelka B E, de Shazo R D, Salvaggio J E. Analytical and functional assessment of lymphoid cells within murine lung. Exp. Lung Res. 1987; 13: 13
   PubMed Web of Science ®Google Scholar
• Itoh H, Abo T, Sugawara S, Kanno A, Kumagai K. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes. J. Immunol. 1988; 141: 315
   PubMed Web of Science ®Google Scholar
• Lauzon W, Yang H, Lemaire I. Comparative analysis of natural killer function in lung, spleen and peripheral blood lymphocytes: evidence of differential characteristics. Regional Immunol. 1990, in press
   PubMedGoogle Scholar
• Wiltrout R A, Herberman R B, Zhang S R, Chirigos M A, Ortaldo J R, Green K M, Talmadge J E. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J. Immunol. 1985; 134: 4267
   PubMed Web of Science ®Google Scholar
• Stein-Streilein J, Bennett M, Mann D, Kumar V. Natural killer cells in mouse lung: surface phenotype, target preference and response to local influenza virus infection. J. Immunol. 1983; 131: 2699
   PubMed Web of Science ®Google Scholar
• Sayers T J, Mason A T, Ortaldo J R. Regulation of human natural killer activity by IFN-γ: lack of a role in interleukin-2 mediated augmentation. J. Immunol. 1986; 136: 2176
   PubMed Web of Science ®Google Scholar
• Voth R, Rossol S, Gallati H, Pracht I, Lauberstein H P, Hess G, Muller W E, Schroder H C, Jochum C, Meyer zum, Buschenfeld K H. In vivo and In vitro induction of natural killer cells by cloned human tumor necrosis factor. Cancer Immunol, Immunotherapy 1988; 27: 128
   PubMedGoogle Scholar
• Endo Y, Matsushima K, Oppenhiem J J. Mechanism of in vitro antitumor effects of interleukin-1 (IL-1). Immunobiol. 1986; 172: 316
   PubMed Web of Science ®Google Scholar
• Welsh R M. Natural killer cells and interferon. CRC Critical Rev. Immunol. 1986; 5: 55
   Google Scholar
• Day R, Lemaire S, Nadeau D, Keith I, Lemaire I. Changes in autacoid and neuropeptide contents of lung cells in asbestos-induced pulmonary fibrosis. Am. Rev. Respls. Dis. 1987; 136: 908
   PubMed Web of Science ®Google Scholar
• Pross H F, Baines M G, Rubin P, Shragge P, Patterson M S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. the quantitation of natural killer cell activity. J. Clin. Immunol. 1981; 1: 51
   PubMed Web of Science ®Google Scholar
• Platsoucas C D, Fernandes G, Good R A, Gupta A. Augmentation of natural killer cytotoxicity by alpha or gamma natural and recombinant interferons and interferon inducers: effect of monocytes. Int. Archs Allergy appl. Immun. 1986; 79: 1
   PubMedGoogle Scholar
• Brunda M J, Tarnowski D, Davatelis V. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells. Int. J. Cancer 1986; 37: 787
   PubMed Web of Science ®Google Scholar
• Dinarello C A, Conti P, Mier J W. Effects of human interleukin-1 on natural killer cell activity: is fever a host defense mechanism for tumor killing? Yale. J. Blol. Med. 1986; 59: 97
   Google Scholar
• Dempsey R A, Dinarello C A, Mier J W, Rosenwasser L J, Allegretta M, Brown T E, Parkinson D R. The differential effects of human leukocytic pyrogen/lymphocyte-activating factor, T cell growth factor and interferon on human natural killer activity. J. Immunol. 1982; 129: 2504
   PubMed Web of Science ®Google Scholar
• Mannel D N, Kist A, Ho A D, Rath U, Reichardt P, Wiedenmann B, Schlick E, Kirchner H. Tumor necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumor necrosis factor. Br. J. Cancer 1989; 60: 585
   PubMedGoogle Scholar
• Ostensen M E, Thiele D L, Lipsky P E. Tumor necrosis factor-alpha enhances cytolytic activity of human natural killer cells. J. Immunol. 1987; 138: 4185
   PubMed Web of Science ®Google Scholar
• Talmadge J E, Tribble H R, Pennington R W, Phillips H, Wiltrout R H. Immunomodulatory and immunotherapeutic properties of recombinant gamma-interferon and recombinant tumor necrosis factor in mice. Cancer Res. 1987; 47: 2563
   PubMed Web of Science ®Google Scholar
• Branca A A, Baglioni C. Evidence that type I and II interferons have different receptors. Nature 1981; 294: 768
   PubMed Web of Science ®Google Scholar